Methadone Treatment Centers in Tennessee

methadone is approved for opioid use disorder involving any opioid — heroin, fentanyl, prescription oxycodone, hydrocodone, or morphine. Tennessee clinicians treat patients whose OUD started with a pain prescription just as readily as those using illicit opioids.

Common extra charges include urine drug-screen add-ons ($10–$50), missed-appointment fees, and pharmacy dispensing fees for take-home methadone doses. Always ask for a written fee schedule before your first visit at any Tennessee provider.

TennCare managed-care organizations (MCOs) in Tennessee all cover MAT, but formulary details, prior-authorization rules, and in-network provider lists vary. Choose the MCO whose network includes your preferred methadone clinics; you can usually switch plans once a year.

Yes. HSA and FSA funds are eligible for all MAT out-of-pocket expenses — copays, medication, counseling, lab tests — because MAT is IRS-qualified medical care. Keep itemized receipts from methadone clinics for tax records.

Clinics maintain a confidential medical record covering diagnosis, treatment plan, drug screens, counseling notes, and dose history. Records are protected by 42 CFR Part 2 — stricter than HIPAA — and cannot be released without your written consent or a specific court order.

Common reasons include lifestyle stabilization (patient and clinician agree to taper), cost barriers, side effects, travel or employment disruption, and desire to try naltrexone after tapering. Many patients resume treatment later — clinics welcome return visits without judgment.

Avoid benzodiazepines, alcohol, and long-acting opioids for 6–12 hours before induction to reduce sedation risk. For buprenorphine, let the clinician know your last opioid use time so they can time the first dose to avoid precipitated withdrawal.

Sometimes. Comfort medications for withdrawal (clonidine, ondansetron, loperamide) may be prescribed alongside methadone at your first visit. Tennessee clinicians will also address any mental-health medications, pain control, or chronic-disease meds that need coordination.

Buprenorphine and methadone do not test positive on standard 5-panel drug tests — specialty panels are needed. Naltrexone and its metabolites are not screened on standard panels. Share an MAT provider letter with any employer or court drug-testing program to avoid confusion.

Yes. Methadone and buprenorphine are compatible with breastfeeding per CDC and AAP guidance; the small amounts in breast milk are protective against NOWS. Naltrexone in breastfeeding is less studied — discuss with your Tennessee OB and MAT provider together.

No — counselors with master’s-level licensure (LCSW, LPC, LMFT) provide therapy but do not prescribe medication. A nurse practitioner, physician assistant, or physician on the Tennessee MAT team handles the prescription. Counselor and prescriber collaborate on your care plan.

No. Legally prescribed methadone, buprenorphine, or naltrexone does not violate employment drug-testing policies when documented by your MAT clinician. Notify the Medical Review Officer (MRO) of your prescription — do not test positive without MRO notification.